Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai
Patent
1995-01-24
1997-01-07
Cain, Edward J.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Peptide containing doai
514 4, 514 12, 514 21, A61K 3710
Patent
active
055917135
ABSTRACT:
(1) A composition which comprises erythropoietin and hyaluronic acid shows a sustained-release of the medicine in a living body, and
(2) A water-soluble composition which comprises (a) a pharmacologically active polypeptide secreted by an animal body or its derivative or a chemically synthesized pharmacologically active substance, (b) a water-soluble species' of hyaluronic acid or its nontoxic salt and (c) a water-soluble protein injectable into body fluids without showing any substantial pharmacological activity brings about a prolonged action in vivo of a pharmacologically active substance. In addition, the composition can be administered using a small-gauge needle and thereby contributes to relieving pain in patients.
REFERENCES:
patent: 3959247 (1976-05-01), Fujino et al.
patent: 4100152 (1978-07-01), Fujino et al.
patent: 4879111 (1989-11-01), Chong
patent: 5416071 (1995-05-01), Igari
Abstract # 90-047916 (Jan. 5, 1990).
Abstract # 90-004036 (Nov. 1989).
Derwent Abstract No. 91-122603/17 corresponding to JP 3-63299-A (Laid-Open).
Derwent Abstract No. 90-004036/01 corresponding to JP 1-287041/1989 (Laid Open).
Derwent Abstract No. 90-047916/07 corresponding to JP 2-213/1990 (Laid Open).
Derwent Abstract No. 91-054446/08 corresponding to JP 3-4790/1991 (Laid Open).
Endocrinology, vol. 129, No. 1, pp. 323-329 (Jul.-Dec. 1991).
The EMBO Journal, vol. 11, No. 5, pp. 1867-1873 (1992).
The Journal of Biological Chemistry, vol. 252, No. 15, pp. 5558-5564 (1977).
The Journal of Biological Chemistry, vol. 262, No. 35, pp. 17156-17163 (Dec., 15, 1987).
Nature, Vil. 313, No. 28, pp. 806-810 (Feb. 1985).
Proc. Natl. Acad. Sci., vol. 82, pp. 7580-7584 (Nov. 1985).
Proceedings of the National Academy of Sciences, vol. 86, pp. 7819-7822 (Oct. 1989).
Endocrinology, vol. 116, No. 6, pp. 2293-2299 (Jan.-Jun. 1985).
Biochimica et Biophysica Acta, vol. 1038, pp. 125-129 (1990).
Agricultural and Biological Chemistry, vol. 52, (6), pp. 1575-1581 (1988).
Igari Yasutaka
Ogawa Yasuaki
Yamada Minoru
Cain Edward J.
Conlin David G.
Lowen Cara Z.
Neuner George W.
Takeda Chemical Industries Ltd.
LandOfFree
Water-soluble composition for sustained-release does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Water-soluble composition for sustained-release, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Water-soluble composition for sustained-release will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1764108